Lupus-Like Immune Complex-Mediated Glomerulonephritis in Patients With Hepatitis C Virus Infection Treated With Oral, Interferon-Free, Direct-Acting Antiviral Therapy

[1]  J. Trotter,et al.  Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[2]  K. Reddy,et al.  Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection. , 2016, Gastroenterology.

[3]  R. Chung,et al.  Treatment of hepatitis C virus–associated mixed cryoglobulinemia with direct‐acting antiviral agents , 2016, Hepatology.

[4]  S. Pungpapong,et al.  Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis , 2015, Hepatology.

[5]  P. Messa,et al.  Rituximab therapy for primary glomerulonephritis: Report on two cases. , 2015, World journal of clinical cases.

[6]  A. Fabbrizzi,et al.  Long‐term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open‐label, cohort study , 2015, Hepatology.

[7]  R. Chung,et al.  Enhancing Our Understanding of Current Therapies for Hepatitis C Virus (HCV) , 2015, Current HIV/AIDS Reports.

[8]  D. Roberts,et al.  Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease. , 2015, Journal of autoimmunity.

[9]  J. Ward,et al.  Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010 , 2014, Annals of Internal Medicine.

[10]  M. Haberal,et al.  Clinicopathologic study of kidney biopsies in patients before or after liver transplant. , 2014, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

[11]  W. Koldingsnes,et al.  Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre. , 2013, Rheumatology.

[12]  T. Tsunoda,et al.  Hepatitis C Virus Infection Suppresses the Interferon Response in the Liver of the Human Hepatocyte Chimeric Mouse , 2011, PloS one.

[13]  V. D’Agati,et al.  Collapsing Focal Segmental Glomerulosclerosis , 2020, Consultant.

[14]  A. McLean,et al.  Severe systemic lupus erythematosus induced by antiviral treatment for hepatitis C. , 2008, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[15]  S. Akira,et al.  Hepatitis C Virus Nonstructural Protein 5A Modulates the Toll-Like Receptor-MyD88-Dependent Signaling Pathway in Macrophage Cell Lines , 2007, Journal of Virology.

[16]  M. Pirisi,et al.  Antiviral treatment of hepatitis C , 2006, Expert opinion on pharmacotherapy.

[17]  B. Julian,et al.  Brief Communication: Glomerulonephritis in Patients with Hepatitis C Cirrhosis Undergoing Liver Transplantation , 2006, Annals of Internal Medicine.

[18]  J. Piette,et al.  Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  G. Mazzucco,et al.  Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy. , 2003, Kidney international.

[20]  D. Vergani,et al.  Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. , 2003, Clinical and experimental immunology.

[21]  S. Dikman,et al.  Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. , 2002, Seminars in arthritis and rheumatism.

[22]  J. Feehally,et al.  Glomerular IgA deposition in liver disease. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  R. Rodby,et al.  Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. , 1993, Journal of the American Society of Nephrology : JASN.

[24]  L. Rönnblom,et al.  Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. , 1991, Annals of internal medicine.

[25]  J. Jennette,et al.  Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. , 1983, Kidney international.